An expert consensus for the management of chronic hepatitis B in Asian Americans.

ABSTRACT:

Background

Hepatitis B virus (HBV) infection is common with major clinical consequences. In Asian Americans, the HBsAg carrier rate ranges from 2% to 16% which approximates the rates from their countries of origin. Similarly, HBV is the most important cause of cirrhosis, hepatocellular carcinoma (HCC) and liver related deaths in HBsAg positive Asians worldwide.

Aim

To generate recommendations for the management of Asian Americans infected with HBV.

Methods

These guidelines are based on relevant data derived from medical reports on HBV from Asian countries as well as from studies in the HBsAg positive Asian Americans. The guidelines herein differ from other recommendations in the treatment of both HBeAg positive and negative chronic hepatitis B (CHB), in the approach t

SUBMITTER: Tong MJ 

PROVIDER: S-EPMC5900913 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature